Boswellia 400 mg

Boswellia serrata is provided in a high amount of 800 mg to assist with a healthy inflammatory response in the joints. However, the use of unstandardized raw herb powder makes it difficult to determine the actual level of active boswellic acids delivered.

While the selection of a single, well-researched botanical provides depth, the lack of extract concentration limits the overall therapeutic predictably. This focused approach is most appropriate for users who prefer whole-plant powders over refined extracts.

Boswellia serrata is valued for its content of boswellic acids, which are specific inhibitors of the 5-LOX enzyme. This enzymatic pathway is a key producer of leukotrienes, which are major mediators of joint and systemic inflammation.

This formulation uses raw powder rather than a standardized extract, which may result in lower bioavailability of the active resins. It provides a significant bulk amount of the herb for those who prefer whole-plant supplementation.